No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PLX Protalix Biotherapeutics
- 1.140
- -0.020-1.72%
Close May 3 16:00 ET
- 1.180
- +0.040+3.47%
Post 16:42 ET
83.58MMarket Cap12.67P/E (TTM)
1.185High1.130Low231.58KVolume1.170Open1.160Pre Close265.74KTurnover0.43%Turnover Ratio12.67P/E (Static)73.32MShares3.31052wk High2.49P/B62.14MFloat Cap1.09052wk Low--Dividend TTM54.51MShs Float1037.500Historical High--Div YieldTTM4.74%Amplitude0.700Historical Low1.147Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...
NYSE American New 52-Week Highs And Lows
New Highs 0 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ New Lows 11 COMPANY SYMBOL LOW
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript
Earnings Call: Protalix BioTherapeutics Reports Fiscal Year 2023 Results
Earnings Call Summary | Protalix Biotherapeutics(PLX.US) Q4 2023 Earnings Conference
The following is a summary of the Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call Transcript:Financial Performance:Protalix reported Q4 revenues of $40.4 million, a significant increase of
Protalix BioTherapeutics Q4 23 Earnings Conference Call At 8:30 AM ET
Comments
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Rockhoundj : I like this one. Weekly chart looks like it’s rounding up from a big bottom.
Gonna start buying lil bit
Whaddya think?
AmyNicOP Rockhoundj: I like it too. It seems to be a low key beast